FOXO3 and hepatocellular carcinoma: Given the absence of additional HCC investigations, novel studies analyzing the relationship of HBV infection or other clinicopathological factors with FOXO3 expression will help unravel the potential of this central transcription factor to predict HCC-associated features and reinforce its usefulness as a novel biomarker.